Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) Other Operating Expenses (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Other Operating Expenses for 10 consecutive years, with $20.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Operating Expenses fell 6.75% to $20.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $82.7 million, a 18.46% increase, with the full-year FY2025 number at $77.4 million, up 16.98% from a year prior.
  • Other Operating Expenses was $20.8 million for Q4 2025 at Orthopediatrics, down from $23.2 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $23.2 million in Q3 2025 to a low of $8.9 million in Q1 2021.
  • A 5-year average of $14.9 million and a median of $14.3 million in 2023 define the central range for Other Operating Expenses.
  • Biggest YoY gain for Other Operating Expenses was 93.52% in 2021; the steepest drop was 35.75% in 2021.
  • Orthopediatrics' Other Operating Expenses stood at $10.1 million in 2021, then increased by 18.25% to $12.0 million in 2022, then increased by 20.02% to $14.4 million in 2023, then surged by 54.83% to $22.3 million in 2024, then decreased by 6.75% to $20.8 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Other Operating Expenses are $20.8 million (Q4 2025), $23.2 million (Q3 2025), and $22.1 million (Q2 2025).